martes, 19 de diciembre de 2023

An adaptive trial design for testing the bioequivalence of generics of highly variable drugs

https://www.fda.gov/drugs/regulatory-science-action/adaptive-trial-design-testing-bioequivalence-generics-highly-variable-drugs?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario